Spencer Pharmaceutical Inc. (SPPH)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Jan 22, 2026
Spencer Pharmaceutical Company Description
Spencer Pharmaceutical Inc. develops drug platform technologies for the treatment of neurological deceases.
The company specializes in the controlled release of existing therapeutic molecules in the areas of central nervous system, which include Alzheimer and Parkinson diseases, and brain cancer; and patented slow release drug delivery technology for the treatment of type-2 diabetes, arthritis, and other potential applications.
It has operations primarily in North America and Europe. The company was incorporated in 1998 and is based in Boston, Massachusetts.
Spencer Pharmaceutical Inc.
| Country | United States |
| Founded | 1998 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 2 |
| CEO | Maximilien Arella |
Contact Details
Address: 8 Faneuil Hall Marketplace Boston, Massachusetts 02109 United States | |
| Phone | 617-973-5017 |
Stock Details
| Ticker Symbol | SPPH |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US8482241010 |
| SIC Code | 5122 |
Key Executives
| Name | Position |
|---|---|
| Dr. Maximilien Arella Ph.D. | Chairman, Chief Executive Officer and President |